February 200 – The CenterWatch Monthly : Volume 7, Issue 2, February 2000
Surfing for Study Subjects
Although service providers have long offered Internet-based patient recruitment solutions; large health portals are eyeing the clinical trials industry as an important revenue source.
The January merger of an SMO--Affiliated Research Centers--and AmericasDoctor.com may facilitate other SMO, and even CRO, alliances with major health portals.
EMR: Gearing Up for Prime Time
Current use of electronic medical records is very low, but pending HIPAA requirements will likely accelerate adoption rates.EMRs are expected to play a dramatic role in reducing development cycle times and costs; the question is, when will they begin to do so?
CentreStage Europe: Russian Market Meets its First SMO
Despite some ongoing problems, the Russian market is becoming a more attractive location in which to conduct clinical trials due to high levels of investigator motivation and a treatment-naive patient population. Geny, a Boston-based SMO, was founded specifically to navigate the problems still to be encountered in Russia when conducting trials.
Eye On: Prostate Cancer
CenterWatch editorial has identified 52 therapies in the clinical research pipeline for the treatment of the most common cancer diagnosed in men--prostate cancer. Primary areas of research include gene therapy, immunologic agents, vaccines, anti-angiogenesis and drug delivery.
- Month in Review
- Opportunities Underway